2-Amino-N-(amino-oxo-aryl-lambda 6-sulfanylidene)acetamide compounds and their therapeutic uses
2-amino-N-(amino-oxo-aryl-λ6-sulfanylidene)acetamide compounds selectively target bacterial leucyl-tRNA synthetases, addressing resistance issues and providing an effective treatment for bacterial infections.
JP7591056B2Active Publication Date: 2024-11-27OXFORD DRUG DESIGN LTD
Patent Information
- Application Number
- JP2022536992
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-12-19
- Filing Date
- 2020-12-18
- Publication Date
- 2024-11-27
- Estimated Expiration
- 2040-12-18
AI Technical Summary
Technical Problem
Current antimicrobial agents face challenges with widespread resistance, necessitating new chemotherapeutic agents that target bacterial aminoacyl-tRNA synthetases to inhibit bacterial infections effectively.
Method used
Development of 2-amino-N-(amino-oxo-aryl-λ6-sulfanylidene)acetamide compounds (ANASIA compounds) that selectively inhibit bacterial leucyl-tRNA synthetases, offering a novel approach to treat bacterial infections.
Benefits of technology
The ANASIA compounds provide a potent mechanism to inhibit bacterial aminoacyl-tRNA synthetases, potentially overcoming resistance issues and effectively treating a wide range of bacterial infections.
✦ Generated by Eureka AI based on patent content.
Smart Images

Figure 0007591056000001 
Figure 0007591056000002 
Figure 0007591056000003
Abstract
The present invention relates generally to the field of therapeutic compounds. More particularly, the present invention relates to the preparation of certain 2-amino-N-(amino-oxo-aryl-λ) tRNA synthetases that inhibit (e.g., selectively inhibit) bacterial aminoacyl-tRNA synthetases (aaRS) (e.g., bacterial leucyl-tRNA synthetases, LeuRS). 6 The present invention relates to (e.g., selectively inhibiting) bacterial aminoacyl-tRNA synthetases, treating disorders ameliorated by the inhibition (e.g., selective inhibition) of bacterial aminoacyl-tRNA synthetases, treating bacterial infections, and other uses of such compounds and compositions, both in vitro and in vivo. [Formula 1] TIFF2023506894000322.tif18141
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Novel n-acyl-arylsulfonamide derivatives as aminoacyl trna synthetase inhibitors
JP2018507257A
2-amino-n-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-TRNA synthetase
WO2018065611A1
